Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Medicin fin fase 1 (da 30) + wash-out 10 das
(PubMed) Hadzik B, Grass H, Mayatepek E, Daldrup T, Hoehn T
Wiley Online Library, pp 382405
NPJ Aging 10 , 7 (2024)
US$ 20.86
US$ 23.36
US$ 23.03
US$ 27.92
US$ 21.97
US$ 20.59
US$ 24.37
US$ 24.53
US$ 21.91
